Vivus, Why the Slide? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus, Why the Slide?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rubble who wrote (2796)	7/21/1997 7:19:00 PM
From: Frostman	of 3991

Rubble, I agree with your thinking on VVUS, Q3 earnings is the ticket. The UK announcement is on deck for the very near future, but if the Q2 earning results couldn't light this think up, I doubt a few more erections in England will either. :-) Why is a 3% increase in July short interest for VVUS a buying signal in this case? off subject Planar (PLNR) releases earnings Wednesday, anybody have a clue if they will beat their estimate? Big volume increases lately on no real news other than a competitor missed earnings by 2 cents. Long on Vivus, (there may be more besides me) hold to the belief that all FDA approved ED meds market each other, and find that I am generally upset at AOL about one thing or another. Frostman

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next